Lorraine Kalia and Suneil Kalia part of ground-breaking research for delivery of therapeutic in Parkinson's disease

LMP's Dr Lorraine Kalia, Associate Professor in the Division of Neurology and Dr Suneil Kalia, Associate Professor in the Division of Neurosurgery are part of a research group leading a world-first clinical trial using focused ultrasound technology to deliver a therapeutic directly to affected brain regions in patients with Parkinson’s disease.
Nov 16 / 2020

LMP's Slava Epelman and Clinton Robbins part of large U of T group receiving funding for COVID-19 research

Dr Clinton Robbins in Laboratory Medicine & Pathobiology (LMP) and Dr Slava Epelman, cross-appointed with LMP and Department of Medicine, Division of Cardiology, are part of a large research group receiving funding from the Canada Foundation for Innovation’s (CFI) Exceptional Opportunities Fund.
Nov 12 / 2020

Allison McGeer collaborates on study showing Coronavirus antibodies last at least three months

Coronavirus antibodies can last at least three months after a person becomes infected with the virus that causes COVID-19, according to a study published on October 8 in Science Immunology.Professor Allison McGeer  
Oct 13 / 2020

Faculty at LMP recognized through prestigious awards

September has brought great recognition to several of our colleagues. We are delighted to announce professors Aubert, Ni and Tsao at the Department of Laboratory Medicine and Pathobiology (LMP) have received distinguished honours.
Sep 30 / 2020
Dec 1 Rapid impact: getting interventions into hospitals, patients and communities (a TR Talk)
TR Talks (Translational Research) | 5:00pm–7:00pm
Dec 2 MHSc Laboratory Medicine: Program information night
Program information event | 5:00pm–7:00pm
Dec 7 Ace2 as rationale therapy for COVID19
Monday seminar series | 4:00pm–5:00pm
Dec 7 Networking in the time of COVID
Networking event | 6:00pm–7:30pm
Dec 7 Residency Programs: meet and greet with current Residents
Program information event | 8:00pm–9:00pm